IMMUNOHISTOLOGICAL RELATION BETWEEN DR ANTIGEN EXPRESSION ON MELANOMA-CELLS AND INFILTRATION BY CD8+ T-CELLS

被引:13
作者
HERSEY, P
JAMAL, O
机构
[1] Immunology and Oncology Unit, Mater Misericordiae Hospital, Royal Newcastle Hospital, Newcastle, NSW, David Maddison Clinical Sciences Building
基金
英国医学研究理事会;
关键词
D O I
10.3109/00313029009063551
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Previous studies have suggested that class II major histocompatibility (MHC) antigen expression on melanoma cells may influence immune responses against melanoma and the nature of lymphocytic infiltrates against the tumor. This question was examined further by immunoperoxidase studies on sections from 29 primary and 30 metastatic melanoma with monoclonal antibodies (MAbs) against different lymphocyte subsets. The results indicated that expression of MHC class II DR* antigens on melanoma cells was associated with increased overall lymphocytic infiltration and that this applied particularly to the CD-epsilon + subset of T cells. The CR3 receptor (CD 11b) was expressed predominantly on T cells and not macrophages but infiltration by CD11b + cells did not correlate strongly with DR expression on melanoma cells. Dual staining with MAbs to CD8 and CD11b revealed that, whereas most of the CD8 + cells in DR - primary melanoma and DR + metastatic melanoma were CD11b +, only approximately 50% of the CD8 + cells in DR + primary melanoma were also CD11b +. Expression of CD11b on T cells was reported to define a suppressor subset of T cells. If the latter is correct the present results suggest that DR expression on primary melanoma is associated with infiltration by the cytotoxic T cell subset, whereas in the absence of DR antigens and in metastases this subset is absent and the predominant subset appears to be CD8 + CD11b + T cells with suppressor activity. The biologic and prognostic significance of these findings remains to be determined.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 30 条
[1]  
ALLEN CA, 1987, CANCER RES, V47, P2919
[2]  
ALTIERI DC, 1988, J IMMUNOL, V141, P2656
[3]   MULTIFACTORIAL ANALYSIS OF MELANOMA - PROGNOSTIC HISTOPATHOLOGICAL FEATURES COMPARING CLARKS AND BRESLOWS STAGING METHODS [J].
BALCH, CM ;
MURAD, TM ;
SOONG, SJ ;
INGALLS, AL ;
HALPERN, NB ;
MADDOX, WA .
ANNALS OF SURGERY, 1978, 188 (06) :732-742
[4]  
BARNABA V, 1987, IMMUNOLOGY, V62, P431
[5]   EXPRESSION OF TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE IN MALIGNANT MYELOBLASTS [J].
BRADSTOCK, KF ;
HEWSON, J ;
KERR, A ;
KABRAL, A ;
LEE, CH ;
HUGHES, WG .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1983, 80 (06) :800-805
[6]   PHENOTYPIC DYNAMICS OF TUMOR PROGRESSION IN HUMAN-MALIGNANT MELANOMA [J].
BROCKER, EB ;
SUTER, L ;
BRUGGEN, J ;
RUITER, DJ ;
MACHER, E ;
SORG, C .
INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (01) :29-35
[7]   HLA-DR ANTIGEN EXPRESSION IN PRIMARY MELANOMAS OF THE SKIN [J].
BROCKER, EB ;
SUTER, L ;
SORG, C .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 82 (03) :244-247
[8]   INFLAMMATORY CELL INFILTRATES IN HUMAN-MELANOMA AT DIFFERENT STAGES OF TUMOR PROGRESSION [J].
BROCKER, EB ;
ZWADLO, G ;
HOLZMANN, B ;
MACHER, E ;
SORG, C .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (04) :562-567
[9]   MEMBRANE-ANTIGENS OF HUMAN-CELLS OF THE MONOCYTE MACROPHAGE LINEAGE STUDIED WITH MONOCLONAL-ANTIBODIES [J].
BROOKS, DA ;
ZOLA, H ;
MCNAMARA, PJ ;
BRADLEY, J ;
BRADSTOCK, KF ;
HANCOCK, WW ;
ATKINS, RC .
PATHOLOGY, 1983, 15 (01) :45-52
[10]   PHENOTYPIC HETEROGENEITY OF THE OKM1-POSITIVE LYMPHOCYTE POPULATION - REACTIVITY OF OKM1 MONOCLONAL-ANTIBODY WITH A SUBSET OF THE SUPPRESSOR CYTO-TOXIC T-CELL POPULATION [J].
CEUPPENS, JL ;
GUALDE, N ;
GOODWIN, JS .
CELLULAR IMMUNOLOGY, 1982, 69 (01) :150-165